Our Products

Gefitinib Tablets IP 250 mg is a medication used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations. It is a targeted therapy that works by inhibiting the epidermal growth factor receptor (EGFR), a protein that helps cancer cells grow and divide. By blocking EGFR, Gefitinib helps slow or stop the growth of cancer cells. The 250 mg dosage is typically taken once daily, as prescribed by a healthcare provider. Common side effects may include diarrhea, skin reactions, and liver enzyme abnormalities. It is important for patients to be monitored regularly while on this medication.